Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018984976> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3018984976 abstract "The emergence of immune checkpoint inhibitors (ICIs) in recent years has transformed the landscape of the management of solid tumors. The advancement of immunotherapy has resulted in a brand new set of adverse outcomes not previously seen in classical chemotherapy. One such adverse effect has been termed as hyperprogressive disease (HPD), a phenomenon characterized by rapid tumor progression, which often leads to devastating outcomes. In this report, we present a unique case of a 48-year-old African American female who initially presented with abdominal pain, fatigue, and weight loss. Subsequent CT scan showed extensive irregular wall and luminal narrowing with an eccentric mass and adenopathy along the portacaval space. Tumor markers were found to be elevated and genetic testing was done. The patient was diagnosed with stage IIIC colon cancer with K-RAS wild type, associated with Lynch syndrome. The patient underwent surgical resection, chemotherapy, and targeted therapy for progressive/stage IV disease. In light of the progression of the disease, pembrolizumab was introduced into the treatment regimen. One month after the treatment, a repeat CT scan showed enlargement of the metastatic lesion with almost double the size. The progression of the disease was so rapid and, ultimately, pembrolizumab administration was withheld and the patient passed away after about two months on pembrolizumab. To our knowledge, this is one of the few cases of HPD reported in patients with advanced colon cancer, particularly in one with Lynch syndrome. Further studies are warranted to understand why some individuals benefit from immunotherapy, whereas others experience grave outcomes." @default.
- W3018984976 created "2020-05-01" @default.
- W3018984976 creator A5022227385 @default.
- W3018984976 creator A5022299782 @default.
- W3018984976 creator A5048600656 @default.
- W3018984976 creator A5086740295 @default.
- W3018984976 date "2020-04-21" @default.
- W3018984976 modified "2023-10-04" @default.
- W3018984976 title "Hyperprogressive Disease in an Advanced Stage Colon Cancer Patient on Pembrolizumab: A Case Report" @default.
- W3018984976 cites W1504535992 @default.
- W3018984976 cites W1940241680 @default.
- W3018984976 cites W1993051520 @default.
- W3018984976 cites W2554618897 @default.
- W3018984976 cites W2592144107 @default.
- W3018984976 cites W2601621622 @default.
- W3018984976 cites W2767931551 @default.
- W3018984976 cites W2783417222 @default.
- W3018984976 cites W2783708539 @default.
- W3018984976 cites W2789072552 @default.
- W3018984976 cites W2891266481 @default.
- W3018984976 cites W2898432308 @default.
- W3018984976 cites W2586611183 @default.
- W3018984976 doi "https://doi.org/10.7759/cureus.7764" @default.
- W3018984976 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7243062" @default.
- W3018984976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32455081" @default.
- W3018984976 hasPublicationYear "2020" @default.
- W3018984976 type Work @default.
- W3018984976 sameAs 3018984976 @default.
- W3018984976 citedByCount "3" @default.
- W3018984976 countsByYear W30189849762022 @default.
- W3018984976 countsByYear W30189849762023 @default.
- W3018984976 crossrefType "journal-article" @default.
- W3018984976 hasAuthorship W3018984976A5022227385 @default.
- W3018984976 hasAuthorship W3018984976A5022299782 @default.
- W3018984976 hasAuthorship W3018984976A5048600656 @default.
- W3018984976 hasAuthorship W3018984976A5086740295 @default.
- W3018984976 hasBestOaLocation W30189849761 @default.
- W3018984976 hasConcept C121608353 @default.
- W3018984976 hasConcept C126322002 @default.
- W3018984976 hasConcept C141071460 @default.
- W3018984976 hasConcept C143998085 @default.
- W3018984976 hasConcept C197934379 @default.
- W3018984976 hasConcept C2777701055 @default.
- W3018984976 hasConcept C2778822529 @default.
- W3018984976 hasConcept C2779134260 @default.
- W3018984976 hasConcept C2780057760 @default.
- W3018984976 hasConcept C2781413609 @default.
- W3018984976 hasConcept C526805850 @default.
- W3018984976 hasConcept C71924100 @default.
- W3018984976 hasConceptScore W3018984976C121608353 @default.
- W3018984976 hasConceptScore W3018984976C126322002 @default.
- W3018984976 hasConceptScore W3018984976C141071460 @default.
- W3018984976 hasConceptScore W3018984976C143998085 @default.
- W3018984976 hasConceptScore W3018984976C197934379 @default.
- W3018984976 hasConceptScore W3018984976C2777701055 @default.
- W3018984976 hasConceptScore W3018984976C2778822529 @default.
- W3018984976 hasConceptScore W3018984976C2779134260 @default.
- W3018984976 hasConceptScore W3018984976C2780057760 @default.
- W3018984976 hasConceptScore W3018984976C2781413609 @default.
- W3018984976 hasConceptScore W3018984976C526805850 @default.
- W3018984976 hasConceptScore W3018984976C71924100 @default.
- W3018984976 hasLocation W30189849761 @default.
- W3018984976 hasLocation W30189849762 @default.
- W3018984976 hasLocation W30189849763 @default.
- W3018984976 hasLocation W30189849764 @default.
- W3018984976 hasOpenAccess W3018984976 @default.
- W3018984976 hasPrimaryLocation W30189849761 @default.
- W3018984976 hasRelatedWork W2777867648 @default.
- W3018984976 hasRelatedWork W2786497694 @default.
- W3018984976 hasRelatedWork W2787221390 @default.
- W3018984976 hasRelatedWork W2916953213 @default.
- W3018984976 hasRelatedWork W2969782175 @default.
- W3018984976 hasRelatedWork W3029766637 @default.
- W3018984976 hasRelatedWork W3153432702 @default.
- W3018984976 hasRelatedWork W3161613553 @default.
- W3018984976 hasRelatedWork W3215044659 @default.
- W3018984976 hasRelatedWork W4225695268 @default.
- W3018984976 isParatext "false" @default.
- W3018984976 isRetracted "false" @default.
- W3018984976 magId "3018984976" @default.
- W3018984976 workType "article" @default.